Breaking Down Japan’s Food Culture
In March 2023, the Japanese medical authorities announced that the new weight loss drug Wegovy—which was in staggering demand across the world, causing shortages everywhere—had been approved to treat obesity in their country. It sounded, at first glance, like great news for Novo Nordisk, the company that makes Ozempic and Wegovy. But industry outlet the Pharma Letter explained that this would not in fact turn out to be much of a boost. They predicted that these drugs would dominate the market in Japan, but that won’t mean much, for a simple reason: there is almost no obesity there. Some 42% of Americans are obese, compared with just 4.5% of Japanese people. Japan, it seems, is the land that doesn’t need Ozempic.I wondered how this could be, and if the answer might offer me a way out of a d...










